| The Effect of Medicare's Annual Wellness Visit on Preventive Care for the Elderly |
| Author(s): Miao Jiang; Danny Hughes; Wenyi Wang |
| Affiliations(s): Miao Jiang (IQVIA); Danny Hughes (Georgia Tech and Neiman HPI); Wenyi Wang (Medstar) |
Publication(s): Preventive Medicine
|
| Document Type(s): Article, |
| Countries: USA, |
C:
Y: |
Health economics, Health policy,
2018 |
|
L:
A: |
English
Observational study, Population Based Study, Public Health, Retrospective cohort analysis, |
|
 |
| |
| |
| Use of Breast Cancer Screening and Its Association with Later Use of Preventive Services among Medicare Beneficiaries |
| Author(s): Stella Kang; Miao Jiang; Richard Duszak, Jr.; Samantha Heller; Danny Hughes; Linda Moy |
| Affiliations(s): Stella Kang (Department of Radiology, NYU School of Medicine); Miao Jiang (IQVIA); |
Publication(s): Radiology
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Health policy, Oncology,
2018 |
|
L:
A: |
English
Observational study, Population Based Study, Public Health, Retrospective cohort analysis, |
|
|
| |
| |
| The impact of the new innovative algorithm in Italy |
| Author(s): Rova A1, Cioni L1, Urbinati D1 |
| Affiliations(s): 1 IQVIA, RWI, Milan, Italy |
Publication(s): ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
|
| Document Type(s): Poster, |
| Countries: Italy, |
C:
Y: |
Health policy, Public Health, Regulatory,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| The evolution of standard monitoring registries in the Italian market |
| Author(s): Cioni L1, Rova A1, Urbinati D1 |
| Affiliations(s): 1 IQVIA, RWI, Milan, Italy |
Publication(s): ISPOR 21st Annual European Congress, 10-14 November 2018, Barcelona, Spain
|
| Document Type(s): Poster, |
| Countries: Italy, |
C:
Y: |
Health policy, Public Health, Regulatory,
2018 |
|
L:
A: |
English
|
|
|
| |
| |
| Comparative Analysis of the Market Penetration of Personalised Medicine Drugs Under the Conditions of AMNOG |
| Author(s): Fischer T, Bonduelle D, Antoni B |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: Germany, |
C:
Y: |
Health economics, Health policy,
2018 |
|
L:
A: |
German
Market impact, |
|
|
| |
| |
| Guidelines in Germany Early Benefit Assessment - Which Guidelines are Considered by Federal Joint Committee for Determining the Appropriate Comparator? |
| Author(s): Scheler E, Stratil AS, Roxlau T, Bonduelle D |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): Abstract, Poster, |
| Countries: Germany, |
C:
Y: |
Guidelines, Health policy,
2018 |
|
L:
A: |
German
Review, |
|
|
| |
| |
| Success Factors for §137h SGB V Assessment of Medical Devices in Germany |
| Author(s): Bonduelle, Doreen; von Hein, Mirko; Scheler, Elisabeth |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: Germany, |
C:
Y: |
Health policy,
2018 |
|
L:
A: |
English
Review, |
|
|
| |
| |
| Overview of German AMNOG Dossiers with Price Analysis Before and After Early Benefit Assessment |
| Author(s): Tremmel M, Batscheider A, Bocuk D, Roxlau T, Antoni B, Elena Mihaylova, Bonduelle D |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany
IQVIA RDS Bulgaria EOOD, Sofia, Bulgaria |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: |
C:
Y: |
Health economics, Health policy, Pricing and reimbursement,
2018 |
|
L:
A: |
English
Pricing & Reimbursement, Review, |
|
|
| |
| |
| The Impact of Label Extensions on the Reimbursed Price of Pharmaceutical Products Assessed According to §35A SGB V in Germany Oncological and Metabolic Diseases |
| Author(s): Schmalhofer C, Eheberg D, Tremmel M, Bocuk D, Roxlau T, Antoni B, Bonduelle D |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): Abstract, |
| Countries: Germany, |
C:
Y: |
Health economics, Health policy, Metabolic Disorders , Oncology, Pricing and reimbursement,
2018 |
|
L:
A: |
English
Cost analysis, Pricing & Reimbursement, |
|
|
| |
| |
| Off-Label Prescription of Drugs Compared to Prescription After Label Extension in Children for Germany |
| Author(s): Gohlke A, Kostev K, Kuschel AS |
| Affiliations(s): IQVIA Commercial GmbH & Co. OHG, Munich, Germany |
| Publication(s): |
| Document Type(s): |
| Countries: |
C:
Y: |
Health policy, Pediatrics, Regulatory,
2018 |
|
L:
A: |
English
Utility analysis, |
|
|
| |
| |
 2 of 12 
|
